Toxic epidermal necrolysis treated with N-acetylcysteine [4]

Journal of the American Academy of Dermatology

Volumn 46, Issue 3, 2002, Pages 469-470

  Vélez, Antonio ^a,b   Moreno, José Carlos ^a,b  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CIPROFLOXACIN; DISULFIRAM; PHENYTOIN; PSEUDOMONIC ACID;

ADULT; ALCOHOLISM; CASE REPORT; CONVULSION; HUMAN; LETTER; MALE; PRIORITY JOURNAL; SKIN BIOPSY; TOXIC EPIDERMAL NECROLYSIS;

EID: 0036121485     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2002.118557     Document Type: Letter

References (13)

1. Toxic epidermal necrolysis: Treatment with pentoxifylline
2. Drug-induced hypersensitivity syndrome and toxic epidermal necrolysis: Treatment with N-acetylcysteine
3. Toxic epidermal necrolysis (Lyell syndrome)
4. Toxic epidermal necrolysis: A review
5. Metabolic predisposition to cutaneous adverse drug reactions
6. Immunopathology of toxic epidermal necrolysis: Keratinocytes, HLA-DR expression, Langerhans cells, and mononuclear cells: An immunopathologic study of five cases
7. Macrophages and tumor necrosis factor-alpha in toxic epidermal necrolysis
8. Importance of the glutathione cycle in drug metabolism
9. HIV-induced cysteine deficiency and T-cell dysfunction: A rationale for treatment with N-acetylcysteine
10. Effect of N-acetylcysteine on plasma cysteine and glutathione following paracetamol administration
11. N-acetylcysteine inhibits production of tumor necrosis factor α and interleukin-1β
12. N-acetylcysteine blocks expression of the skin homing receptor cutaneous lymphocyte-associated antigen
13. Hazards of therapy with high doses of N-acetylcysteine for anticonvulsant-induced hypersensitivity syndrome